IBCL - 236
Treatment Preferences and Perceived Barriers to Epcoritamab Plus Rituximab and Lenalidomide in Relapsed/Refractory Follicular Lymphoma: A Real-World Survey of US Hematologists/Oncologists
Blaise Nwotchouang
Poster Presenter: Blaise Nwotchouang
